Safety of Accelerated Infliximab Infusions in Patients With Inflammatory Bowel Disease (IBD)
Status:
Completed
Trial end date:
2016-04-01
Target enrollment:
Participant gender:
Summary
This study aims to test the hypothesis that the accelerated infusion of infliximab is not
inferior to the conventional 2 hour infusion with respect to the frequency of infusion
reaction.